HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paola Barboro Selected Research

Nuclear Matrix-Associated Proteins

10/2015Expression of nuclear matrix proteins binding matrix attachment regions in prostate cancer. PARP-1: New player in tumor progression.
8/2012Prognostic value of nuclear matrix protein expression in localized prostate cancer.
1/2012The role of nuclear matrix proteins binding to matrix attachment regions (Mars) in prostate cancer cell differentiation.
11/2005Nuclear matrix protein expression in prostate cancer: possible prognostic and diagnostic applications.
6/2003Nuclear matrix proteins changes in cancerous prostate tissues and their prognostic value in clinically localized prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paola Barboro Research Topics

Disease

19Neoplasms (Cancer)
09/2022 - 06/2003
19Prostatic Neoplasms (Prostate Cancer)
07/2020 - 06/2003
4Carcinogenesis
10/2014 - 03/2006
3Carcinoma (Carcinomatosis)
01/2012 - 06/2009
2Circulating Neoplastic Cells
07/2020 - 09/2019
2Colorectal Neoplasms (Colorectal Cancer)
04/2020 - 01/2020
1Breast Neoplasms (Breast Cancer)
09/2022
1Inflammation (Inflammations)
01/2017
1Disease Progression
08/2012
1Adenocarcinoma
08/2012
1Urinary Bladder Neoplasms (Bladder Cancer)
01/2008

Drug/Important Bio-Agent (IBA)

14Proteins (Proteins, Gene)FDA Link
09/2022 - 06/2003
7Androgen Receptors (Androgen Receptor)IBA
01/2020 - 09/2011
6AndrogensIBA
12/2019 - 08/2012
6Heterogeneous-Nuclear Ribonucleoprotein KIBA
06/2018 - 06/2009
5Nuclear Matrix-Associated ProteinsIBA
10/2015 - 06/2003
4Aspartic Acid (Aspartate)FDA Link
09/2022 - 01/2020
4Mixed Function Oxygenases (Monooxygenases)IBA
09/2022 - 01/2020
2Messenger RNA (mRNA)IBA
07/2020 - 01/2020
2Notch ReceptorsIBA
04/2020 - 01/2020
2LigandsIBA
04/2020 - 01/2020
2Celecoxib (Celebrex)FDA Link
12/2019 - 01/2017
2Hormones (Hormone)IBA
08/2012 - 06/2009
2ChromatinIBA
01/2012 - 01/2009
2Matrix Attachment Region Binding ProteinsIBA
01/2012 - 01/2009
1PeriostinIBA
07/2020
1Extracellular Matrix ProteinsIBA
07/2020
1Phenobarbital (Luminal)FDA Link
04/2020
1Calcibiotic Root Canal SealerIBA
04/2020
1etoposide phosphate (Etopophos)FDA Link
01/2020
1Type II DNA Topoisomerases (Topoisomerase II)IBA
01/2020
1Epidermal Growth Factor (EGF)IBA
01/2020
1Etoposide (VP 16)FDA LinkGeneric
01/2020
1Cetuximab (Erbitux)FDA Link
12/2019
1Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA
06/2018
1Biological ProductsIBA
12/2017
1Phosphotransferases (Kinase)IBA
01/2017
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2017
1CateninsIBA
08/2012
1Hormone AntagonistsIBA
08/2012
1imidazole mustard (BIC)IBA
09/2011
1afimoxifene (hydroxytamoxifen)IBA
09/2011
1bicalutamide (Casodex)FDA LinkGeneric
09/2011
1Pharmaceutical PreparationsIBA
06/2009
1Docetaxel (Taxotere)FDA Link
06/2009
1Dihydrotachysterol (AT 10)IBA
06/2009
1Biomarkers (Surrogate Marker)IBA
01/2008
1Lamin Type B (Lamin B)IBA
03/2006
1LaminsIBA
03/2006

Therapy/Procedure

9Castration
07/2020 - 08/2012
7Therapeutics
12/2019 - 06/2009
1Lasers (Laser)
01/2012
1Drug Therapy (Chemotherapy)
06/2009
1Prostatectomy (Retropubic Prostatectomy)
06/2003